Penumbra (PEN) Preferred Stock Liabilities (2014)

Penumbra's (PEN) quarterly Preferred Stock Liabilities came in at $111.5 million in Q4 2014.

Analysis

Penumbra (PEN) Preferred Stock Liabilities (2014) Analysis & Trends

Penumbra (PEN) has reported Preferred Stock Liabilities for 1 consecutive years, with $111.5 million the latest figure, recorded in Q4 2014.

On a quarterly basis, Preferred Stock Liabilities changed N/A year-over-year to $111.5 million in Q4 2014; TTM through Dec 2014 was $111.5 million, a N/A change from a year earlier, with the FY2014 full-year figure at $111.5 million, up 98.26% from the prior year.
Preferred Stock Liabilities was $111.5 million for Q4 2014 at Penumbra.
Over five years, Preferred Stock Liabilities peaked at $111.5 million in Q4 2014 and troughed at $111.5 million in Q4 2014.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Stock Liabilities (Qtr)
1	Abbott Laboratories	183.43 Bn	177.83 Bn	7.27 Bn	-
2	Intuitive Surgical	124.55 Bn	119.33 Bn	1.96 Bn	-
3	Medtronic	117.91 Bn	109.10 Bn	6.34 Bn	-
4	Stryker	105.51 Bn	102.03 Bn	4.50 Bn	-
5	Boston Scientific	66.23 Bn	65.69 Bn	3.85 Bn	-
6	Edwards Lifesciences	49.46 Bn	45.21 Bn	1.35 Bn	-
7	Alcon	33.87 Bn	32.41 Bn	1.68 Bn	-
8	Dexcom	32.08 Bn	30.13 Bn	830.00 Mn	-
9	Steris	21.05 Bn	20.56 Bn	684.20 Mn	-
10	Penumbra	12.58 Bn	11.92 Bn	264.94 Mn	-

Historic Data

Download Data

Date	Value
Dec 31, 2014	111.47 Mn